China Pharma Holdings, Inc.CPHINYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank14
Studio
Year-over-Year Change

Return on equity

Latest
-61.13%
Near historical average
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-62.86%
Historical baseline
PeriodValueYoY Change
2024-61.13%-48.0%
2023-41.30%+55.4%
2022-92.61%-63.9%
2021-56.49%-57.7%
2020-35.81%+84.0%
2019-224.11%-529.5%
2018-35.60%+20.5%
2017-44.76%-187.1%
2016-15.59%+26.5%
2015-21.21%-